rs1441438

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000519833.5(IL7):​n.267+6940C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 151,736 control chromosomes in the GnomAD database, including 8,404 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8404 hom., cov: 32)

Consequence

IL7
ENST00000519833.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.167

Publications

14 publications found
Variant links:
Genes affected
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7XM_011517522.4 linkc.414+6940C>T intron_variant Intron 5 of 5 XP_011515824.1
IL7XM_011517523.4 linkc.414+6940C>T intron_variant Intron 5 of 5 XP_011515825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7ENST00000519833.5 linkn.267+6940C>T intron_variant Intron 3 of 6 5
IL7ENST00000523959.5 linkn.121+6940C>T intron_variant Intron 2 of 4 3
ENSG00000296852ENST00000743040.1 linkn.433-55G>A intron_variant Intron 3 of 3
ENSG00000296852ENST00000743041.1 linkn.216-55G>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47800
AN:
151618
Hom.:
8386
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.467
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.250
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.0941
Gnomad SAS
AF:
0.237
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.262
Gnomad OTH
AF:
0.333
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.315
AC:
47859
AN:
151736
Hom.:
8404
Cov.:
32
AF XY:
0.313
AC XY:
23247
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.467
AC:
19349
AN:
41404
American (AMR)
AF:
0.250
AC:
3794
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1492
AN:
3466
East Asian (EAS)
AF:
0.0941
AC:
486
AN:
5164
South Asian (SAS)
AF:
0.236
AC:
1139
AN:
4820
European-Finnish (FIN)
AF:
0.262
AC:
2769
AN:
10556
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.262
AC:
17795
AN:
67828
Other (OTH)
AF:
0.333
AC:
703
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1609
3218
4827
6436
8045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.282
Hom.:
12080
Bravo
AF:
0.318
Asia WGS
AF:
0.208
AC:
724
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
3.4
DANN
Benign
0.32
PhyloP100
0.17

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1441438; hg19: chr8-79641769; API